Search

Recursion Pharmaceuticals Inc

Lezárt

SzektorEgészségügy

3.91 -1.76

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

3.93

Maximum

4.36

Fő mutatók

By Trading Economics

Bevétel

-14M

-131M

Értékesítés

1.2M

7.7M

Egy részvényre jutó nyereség

-0.25

Profit margin

-1,708.018

Munkavállalók

600

EBITDA

-10M

-113M

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+52.52% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 4.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

876M

2.6B

Előző nyitás

5.67

Előző zárás

3.91

Recursion Pharmaceuticals Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. okt. 12. 20:02 UTC

Recursion Pharmaceuticals Inc shares are sharply lower, continuing a downward trend since Friday, despite an early spike in today's trading session.

2026. okt. 10. 00:01 UTC

Recursion Pharmaceuticals Inc shares advanced during after-market hours on Friday, despite earlier pulling back from a session high.

2026. okt. 9. 23:01 UTC

Recursion Pharmaceuticals Inc is trading modestly higher in after-market hours, recovering from an earlier decline while remaining well above its 20-day moving average.

2026. okt. 8. 20:01 UTC

News
Correlated Moves

Recursion Pharmaceuticals faces downward pressure amid significant insider transactions, including a 50k share sale by Director Borgeson Blake on October 6.

2026. okt. 7. 23:05 UTC

Recursion Pharmaceuticals Inc is trading lower in after-market hours, continuing a trend of three consecutive sessions finishing lower since Wednesday's close.

2026. okt. 6. 20:02 UTC

Correlated Moves
Social Media
News

Recursion Pharmaceuticals Inc. shares fell amid sector declines, with attention on upcoming Phase 2 data for REC-4881 and ongoing trials for other candidates.

2026. okt. 5. 23:01 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, continuing lower since Monday's close, despite remaining above its 20-day moving average.

2026. okt. 2. 20:07 UTC

Correlated Moves

Recursion Pharmaceuticals Inc is trading higher, supported by a favorable market environment and positive sentiment following recent labor statistics.

2026. okt. 1. 23:01 UTC

Recursion Pharmaceuticals Inc saw modest gains in after-market hours, reaching a peak increase before settling lower, remaining near the upper end of its one-month range.

2026. szept. 30. 23:30 UTC

Correlated Moves

Recursion Pharmaceuticals Inc is trading higher in after-market hours, reflecting a broader market trend amid positive developments in technology and a revised U.S. GDP growth rate.

2026. szept. 29. 23:31 UTC

Recursion Pharmaceuticals Inc shares declined modestly in after-market trading, moving lower from Tuesday's close, currently around 0.74%, but above its 20-day moving average.

2026. szept. 28. 19:35 UTC

Social Media

Recursion Pharmaceuticals Inc shares fell amid commentary on its role in AI-driven drug design, reflecting a decline since Friday's close.

2026. szept. 25. 23:50 UTC

Recursion Pharmaceuticals Inc has advanced in after-market trading, remaining above its 20-day moving average and near the upper end of its one-month trading range.

2026. szept. 24. 20:07 UTC

Correlated Moves

Recursion Pharmaceuticals is advancing amid a positive biotechnology trend, gaining alongside the ARK Genomic Revolution ETF, which benefits from favorable news from its holdings.

2026. szept. 23. 23:21 UTC

Recursion Pharmaceuticals Inc is advancing in after-market trading, rising sharply since Wednesday's close and remaining above its 20-day moving average.

2026. szept. 22. 19:50 UTC

Social Media

Recursion Pharmaceuticals' stock is advancing after extending a data license agreement with Tempus AI, involving $42 million in committed payments over three years.

2026. szept. 21. 23:30 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, contrasting with recent gains, though it remains above its 20-day moving average.

2026. szept. 19. 00:01 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, moving lower since Friday's close, with notable momentum shifts observed during the session.

2026. szept. 18. 23:41 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, moving lower since Friday's close, despite remaining significantly above its 20-day moving average.

2026. szept. 17. 23:01 UTC

Correlated Moves

Recursion Pharmaceuticals Inc is trading modestly lower in after-market hours, moving in sympathy with Schrodinger Inc amid mixed economic indicators.

2026. szept. 16. 22:51 UTC

Correlated Moves

Recursion Pharmaceuticals Inc is moving higher in after-market trading, reflecting broader market gains following a sharp rise in U.S. retail sales in August.

2026. szept. 15. 23:02 UTC

Recursion Pharmaceuticals Inc. shares are higher in after-market trading, following the broader market's upward trend despite no specific company news.

2026. szept. 14. 20:08 UTC

Correlated Moves

Recursion Pharmaceuticals is gaining today, benefiting from Schrödinger's collaboration agreement with Tectora Therapeutics. Earlier, shares pulled back but have since recovered.

2026. szept. 11. 19:46 UTC

Recursion Pharmaceuticals Inc shares are higher during Friday's session, despite a slight pullback from earlier highs. No specific news was identified for the move.

2026. szept. 10. 23:16 UTC

No specific news was identified for Recursion Pharmaceuticals Inc. during after-market hours. The stock remained roughly flat since Thursday's close.

2026. szept. 9. 23:06 UTC

Recursion Pharmaceuticals Inc shares are higher in after-market trading, following a notable peak earlier in the session with no specific news identified.

2026. szept. 8. 22:51 UTC

Recursion Pharmaceuticals Inc shares are higher in after-market trading. The stock remains above its 20-day moving average and near the upper end of its one-month range.

2026. szept. 4. 20:08 UTC

Recursion Pharmaceuticals shares are higher today, continuing an upward trend since Thursday's close, amid broader market dynamics following a strong jobs report.

2026. szept. 3. 23:21 UTC

Correlated Moves

Recursion Pharmaceuticals Inc. shares declined in after-market trading, following a peak shortly after the market closed and amid broader market weakness.

2026. szept. 2. 23:06 UTC

Recursion Pharmaceuticals Inc shares are lower in after-market trading. The decline comes amid a weaker ADP private payrolls report impacting overall market sentiment.

Társak összehasonlítása

Árváltozás

Recursion Pharmaceuticals Inc Előrejelzés

Célár

By TipRanks

52.52% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 6.65 USD  52.52%

Magas 8 USD

Alacsony 5.3 USD

5 Wall Street elemző 12 hónapos célárain alapulva a(z)Recursion Pharmaceuticals Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

5 ratings

2

Vétel

3

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
help-icon Live chat